Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance
- PMID: 24602822
- DOI: 10.1016/j.semcancer.2014.02.010
Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance
Abstract
Human cancers constitutively produce and release endosome-derived nanometer-sized vesicles called exosomes that carry biologically active proteins, messenger and micro RNAs and serve as vehicles of intercellular communication. The tumour exosomes are present in the blood, urine and various malignant effusions such as peritoneal and pleural fluid of cancer patients and can modulate immune cells and responses thus deranging the immune system of cancer patients and giving advantage to the cancer to establish and spread itself. Here, the role of exosomes in the NKG2D receptor-ligand system's interactions is discussed. The activating NK cell receptor NKG2D and its multiple ligands, the MHC class I-related chain (MIC) A/B and the retinoic acid transcript-1/UL-16 binding proteins (RAET1/ULBP) 1-6 comprise a powerful stress-inducible danger detector system that targets infected, inflamed and malignantly transformed cells and plays a decisive role in anti-tumour immune surveillance. Mounting evidence reveals that the MIC- and RAET1/ULBP ligand family members are enriched in the endosomal compartment of various tumour cells and expressed and released into the intercellular space and bodily fluids on exosomes thus preserving their entire molecule, three-dimensional protein structure and biologic activity. The NKG2D ligand-expressing exosomes serve as decoys with a powerful ability to down regulate the cognate receptor and impair the cytotoxic function of NK-, NKT-, gamma/delta- and cytotoxic T cells. This review summarizes recent findings concerning the role of NKG2D receptor-ligand system in cancer with emphasis on regulation of NKG2D ligand expression and the immunosuppressive role of exosomally expressed NKG2D ligands.
Keywords: Cancer; Cytotoxicity; Exosomes; Immune suppression; MICA/B; NK cells; NKG2D; RAET1; Tumour surveillance; ULBP.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity.Tumour Biol. 2016 Apr;37(4):5455-66. doi: 10.1007/s13277-015-4313-2. Epub 2015 Nov 13. Tumour Biol. 2016. PMID: 26563374
-
Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Scand J Immunol. 2013 Aug;78(2):120-9. doi: 10.1111/sji.12072. Scand J Immunol. 2013. PMID: 23679194 Review.
-
Ras activation induces expression of Raet1 family NK receptor ligands.J Immunol. 2012 Aug 15;189(4):1826-34. doi: 10.4049/jimmunol.1200965. Epub 2012 Jul 13. J Immunol. 2012. PMID: 22798674
-
Targeting NKG2D in tumor surveillance.Expert Opin Ther Targets. 2012 Jun;16(6):587-99. doi: 10.1517/14728222.2012.681378. Epub 2012 Apr 25. Expert Opin Ther Targets. 2012. PMID: 22530569 Review.
-
Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.J Immunol. 2009 Jul 1;183(1):340-51. doi: 10.4049/jimmunol.0803477. J Immunol. 2009. PMID: 19542445
Cited by
-
The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response.Cancer Biol Ther. 2024 Dec 31;25(1):2356831. doi: 10.1080/15384047.2024.2356831. Epub 2024 May 20. Cancer Biol Ther. 2024. PMID: 38767879 Free PMC article. Review.
-
Diversity of Intercellular Communication Modes: A Cancer Biology Perspective.Cells. 2024 Mar 12;13(6):495. doi: 10.3390/cells13060495. Cells. 2024. PMID: 38534339 Free PMC article. Review.
-
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises.Cells. 2024 Feb 13;13(4):337. doi: 10.3390/cells13040337. Cells. 2024. PMID: 38391950 Free PMC article. Review.
-
Protein cargo in extracellular vesicles as the key mediator in the progression of cancer.Cell Commun Signal. 2024 Jan 10;22(1):25. doi: 10.1186/s12964-023-01408-6. Cell Commun Signal. 2024. PMID: 38200509 Free PMC article. Review.
-
Tumor immune escape: extracellular vesicles roles and therapeutics application.Cell Commun Signal. 2024 Jan 2;22(1):9. doi: 10.1186/s12964-023-01370-3. Cell Commun Signal. 2024. PMID: 38167133 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials